Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 17 of 23
Efficacy of Nitric Oxide Administration in Attenuating Ischemia/Reperfusion Injury During Neonatal Cardiopulmonary Bypass
NCT02151877
Systolic Blood Pressure Measurement in Critically-ill Patients
NCT02366507
Breast Health Education for Underserved Latino Women
NCT02205736
Pain Expectations in Subjects With Osteoarthritis
NCT02155257
Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases
NCT01767935
Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant
NCT02109809
Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients
NCT02606279
Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils
NCT02337231
ROP Screening: Comparison of Pain Using Two Eyelid Retractors
NCT02152046
Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain
NCT02100956
A Study of Regorafenib in Advanced Pancreatic Cancer Patients
NCT02080260
Continuous Infusion Versus Bolus Dosing for Pain Control After Pediatric Cardiothoracic Surgery
NCT02112448
Effectiveness of an mHealth Colorectal Cancer Screening Intervention
NCT02088333
LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer
NCT02164942
Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery
NCT03612687
Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy
NCT02023008
Multivitamin Adherence Following Bariatric Surgery
NCT02124889
Stress and Coping in Caregivers of Younger Patients With Cancer
NCT02725385
Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome
NCT02440373
Effects of a Cocoa Shot on the Human Brain 2
NCT02080845
Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections
NCT02099227
Exhaled NO as a Biomarker of Gestational OSA and Persistence Postpartum
NCT02100943
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
NCT01988571
Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy
NCT01941810
Impact of Weight Loss on Physical Function
NCT02079051
Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy
NCT02011087
Efficacy of Spinal Oxytocin in Healthy Volunteers
NCT01996605
Tolerability and Satisfaction With Evie
NCT01969812
Latinos Combating Diabetes
NCT01831921
Vitamin D Supplementation and Muscle Function in Older Adults
NCT02015611
Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy
NCT01941784
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
NCT01985828
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
NCT01869764
HEART Pathway Implementation
NCT02056964
LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia
NCT01999556
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
NCT01941758
CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
NCT01931787
High-resolution, Relational, Resonance-based, Electroencephalic Mirroring (HIRREM) to Relieve Insomnia
NCT01971567
Bupivacaine for Benign Headache in the ED
NCT01785459
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
NCT02181387
Effects of a Cocoa Shot on the Human Brain
NCT01924481
Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin
NCT01931852
Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
NCT01950923
Combined Spinal-Epidural Temperature and Duration of Action
NCT02020304
Comparing Types of Implementation of a Shared Decision Making Intervention
NCT02047929
ClinicCompanion. Compared to the Use of a Goniometer
NCT02043639
CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy
NCT01902381
Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia
NCT01869777
CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
NCT01839981
Evaluation of Efficacy and Accuracy of Aquamantys Device in General Surgery
NCT01929902
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.